0.100
0.00 (1.01%)
Penutupan Terdahulu | 0.099 |
Buka | 0.100 |
Jumlah Dagangan | 5,000 |
Purata Dagangan (3B) | 125,460 |
Modal Pasaran | 29,806,702 |
Harga / Jualan (P/S) | 3.87 |
Harga / Buku (P/B) | 1.57 |
Julat 52 Minggu | |
Tarikh Pendapatan | 29 Jan 2025 - 3 Feb 2025 |
Margin Keuntungan | -175.04% |
Margin Operasi (TTM) | -214.84% |
EPS Cair (TTM) | -0.050 |
Pertumbuhan Hasil Suku Tahunan (YOY) | -2.50% |
Jumlah Hutang/Ekuiti (D/E MRQ) | 16.18% |
Nisbah Semasa (MRQ) | 5.03 |
Aliran Tunai Operasi (OCF TTM) | -14.06 M |
Aliran Tunai Bebas Leveraj (LFCF TTM) | -13.11 M |
Pulangan Atas Aset (ROA TTM) | -32.72% |
Pulangan Atas Ekuiti (ROE TTM) | -58.81% |
Arah Aliran Pasaran
Jangka Pendek | Jangka Sederhana | ||
Industri | Medical Devices (AU) | Bercampur | Bercampur |
Medical Devices (Global) | Bercampur | Bercampur | |
Stok | UNI BIOSEN CDI 1:1 [UBI] | - | - |
AISkor Stockmoo
Konsensus Penganalisis | 0.0 |
Aktiviti Orang Dalam | NA |
Volatiliti Harga | 0.5 |
Purata Bergerak Teknikal | 0.0 |
Osilator Teknikal | -2.5 |
Purata | -0.50 |
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets. |
|
Sektor | Healthcare |
Industri | Medical Devices |
Gaya Pelaburan | Small Growth |
% Dimiliki oleh Orang Dalam | 10.19% |
% Dimiliki oleh Institusi | 42.77% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
Keuntungan Nyata | - |
Keuntungan Tidak Nyata | - |
Dividen Diterima 2025 | - |
Jumlah Untung | - |
Pulangan Purata | - |
Kuantiti (Beli) | - |
Purata Harga (Beli) | - |
Kuantiti (Jual) | - |
Purata Harga (Jual) | - |